Back
Aldeyra Therapeutics Stock Price Chart

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65
ALDX
Aldeyra Therapeutics
Last Price:
$6.61
Seasonality Move:
17.74%
7 Day Trial
ALL ACCESS PASS
$
7

Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and ALDX is experiencing selling pressure, which indicates risk of future bearish movement.
Aldeyra Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.69 | Sell |
20-day SMA: | 6.47 | Buy |
50-day SMA: | 5.85 | Buy |
200-day SMA: | 5.04 | Buy |
8-day EMA: | 6.61 | Sell |
20-day EMA: | 6.45 | Buy |
50-day EMA: | 6.03 | Buy |
200-day EMA: | 5.26 | Buy |
Aldeyra Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.21 | Buy |
Relative Strength Index (14 RSI): | 53.63 | Buy |
Chaikin Money Flow: | -363642 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.09 - 6.85) | Buy |
Bollinger Bands (100): | (4.76 - 6.14) | Buy |
Aldeyra Therapeutics Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aldeyra Therapeutics Stock
Is Aldeyra Therapeutics Stock a Buy?
-
Aldeyra Therapeutics share price is 6.58 while ALDX 8-day simple moving average is 6.69, which is a Sell signal.
-
The stock price of ALDX is 6.58 while Aldeyra Therapeutics 20-day SMA is 6.47, which makes it a Buy.
-
Aldeyra Therapeutics 50-day simple moving average is 5.85 while ALDX share price is 6.58, making it a Buy technically.
-
ALDX stock price is 6.58 and Aldeyra Therapeutics 200-day simple moving average is 5.04, creating a Buy signal.
ALDX Technical Analysis vs Fundamental Analysis
Buy
65
Aldeyra Therapeutics (ALDX)
is a Buy
Is Aldeyra Therapeutics a Buy or a Sell?
-
Aldeyra Therapeutics stock is rated a BuyThe current Aldeyra Therapeutics [ALDX] share price is $6.58. The Score for ALDX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Aldeyra Therapeutics Stock Info
Market Cap:
392.9M
Price in USD:
6.58
Share Volume:
675.3K
Aldeyra Therapeutics 52-Week Range
52-Week High:
7.20
52-Week Low:
2.85
Buy
65
Aldeyra Therapeutics (ALDX)
is a Buy
Aldeyra Therapeutics Share Price Forecast
-
What is the Aldeyra Therapeutics stock price today?The Aldeyra Therapeutics stock price is 6.58 USD today.
-
Will ALDX stock go up or go down?Aldeyra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aldeyra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aldeyra Therapeutics is not overvalued.
Is Aldeyra Therapeutics Stock a Buy?
-
Aldeyra Therapeutics share price is 6.58 while ALDX 8-day exponential moving average is 6.61, which is a Sell signal.
-
The stock price of ALDX is 6.58 while Aldeyra Therapeutics 20-day EMA is 6.45, which makes it a Buy.
-
Aldeyra Therapeutics 50-day exponential moving average is 6.03 while ALDX share price is 6.58, making it a Buy technically.
-
ALDX stock price is 6.58 and Aldeyra Therapeutics 200-day simple moving average is 5.26, creating a Buy signal.
Fundamental Analysis of Aldeyra Therapeutics
Is Aldeyra Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and a decrease next year of $0.20 per share.
Technical Analysis of Aldeyra Therapeutics
Should I short Aldeyra Therapeutics stock?
-
ALDX Moving Average Covergence Divergence (MACD) indicator is 0.21, suggesting Aldeyra Therapeutics is a Buy
-
Aldeyra Therapeutics Relative Strength Index (RSI) is 53.63, which suggest Aldeyra Therapeutics is overbought
-
The Bollinger Bands (25) for Aldeyra Therapeutics is (6.09 - 6.85), which suggest Aldeyra Therapeutics is a Buy
-
The Bollinger Bands (100) for Aldeyra Therapeutics is (4.76 - 6.14), which suggest Aldeyra Therapeutics is a Buy
* Aldeyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.